Guillain‐Barré Syndrome and Influenza Virus Infection

Sivadon-Tardy, Valérie; David, Olivier; Porcher, Raphaël; Sharshar, Tarek; Durand, Marie-Christine; Enouf, Vincent; Rozenberg, Flore; Caudie, Christiane; Annane, Djillali; Werf, Sylvie van der; Lebon, Pierre; Raphaël, Jean-Claude; Gaillard, Jean‐Louis; Gault, Elyanne

doi:10.1086/594124

Cited by 137 publications

(91 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In addition, data from the systems monitoring influenza A(H1N1) 2009 monovalent vaccines suggest that the increased risk for GBS is approximately one or two additional cases per 1 million persons vaccinated, which is similar to that observed in some years for seasonal IIV (350)(351)(352)(353)(354)(355)(356). Studies have also shown an increased risk for GBS following influenza infection, of higher magnitude than the risk observed following influenza vaccination (338,357).…”

Section: Guillain-barré Syndrome and Iivmentioning

confidence: 62%

Prevention and Control of Seasonal Influenza with Vaccines

Grohskopf

Sokolow²,

Broder³

et al. 2016

MMWR Recomm. Rep.

383

279

View full text Add to dashboard Cite

Section: Guillain-barré Syndrome and Iivmentioning

confidence: 62%

Prevention and Control of Seasonal Influenza with Vaccines

Grohskopf

Sokolow²,

Broder³

et al. 2016

MMWR Recomm. Rep.

383

279

View full text Add to dashboard Cite

“…Seasonal influenza A and B have been serologically associated with GBS [6,7]. However, this association has been very scarce and has not been reported with the AMAN variant.…”

Section: Discussionmentioning

confidence: 99%

Acute Motor Axonal Neuropathy Associated with Pandemic H1N1 Influenza A Infection

et al. 2010

View full text Add to dashboard Cite

show abstract

“…The most common pathogen associated with GBS is Campylobacter jejuni [4]. In addition, GBS cases have been reported following cytomegalovirus [7], Epstein-Barr virus [8], Mycoplasma pneumoniae [9], Haemophilus influenza [10], influenza virus [11], Hepatitis E [12], Dengue [13], Chikungunya (CHIKV) [14] and Zika virus (ZIKV) infections [15], among others. Moreover, vaccination campaigns against influenza A (H1N1) [4] and rabies prophylactic vaccination [16] were associated with a small risk of GBS.…”

Section: Introductionmentioning

confidence: 99%

Guillain–Barré syndrome in Colombia: where do we stand now?

Mahecha

Ojeda²,

Vega³

et al. 2016

Immunol Res

View full text Add to dashboard Cite

Guillain-Barré syndrome (GBS) is a rapid-onset muscle weakness disease caused by the immune-mediated damage of the peripheral nervous system. Since there is an increase incidence of GBS cases in Latin America, particularly in Colombia, and most of them are currently preceded by Zika virus (ZIKV) infection, we aimed to assess the available evidence of the disease in Colombia through a systematic literature review. Out of 51 screened abstracts, only 16 corresponded to articles that met inclusion criteria, of which 15 were case reports or case series. A total of 796 cases of GBS were reported in the included articles. The majority of patients were males (66.8 %) and younger than 50 years old (94 %). An infectious disease before the onset of GBS was registered in 31 % of patients, with gastrointestinal or respiratory symptoms being the most frequently observed. In those cases in which electrodiagnostic tests were performed, the most common subphenotype was acute inflammatory demyelinating polyneuropathy (17 %). Death was reported in 15 % of patients. Data regarding GBS in Colombia is scant and heterogeneous. Taking into account the burden of the disease and the recent rise of GBS cases associated with ZIKV, a careful patient evaluation and a systematic collection of data are warranted. A form to data gathering is proposed.

show abstract

Guillain‐Barré Syndrome and Influenza Virus Infection

Cited by 137 publications

References 35 publications

Prevention and Control of Seasonal Influenza with Vaccines

Prevention and Control of Seasonal Influenza with Vaccines

Acute Motor Axonal Neuropathy Associated with Pandemic H1N1 Influenza A Infection

Guillain–Barré syndrome in Colombia: where do we stand now?

Contact Info

Product

Resources

About